TR200200467T2 - Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi. - Google Patents

Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.

Info

Publication number
TR200200467T2
TR200200467T2 TR2002/00467T TR200200467T TR200200467T2 TR 200200467 T2 TR200200467 T2 TR 200200467T2 TR 2002/00467 T TR2002/00467 T TR 2002/00467T TR 200200467 T TR200200467 T TR 200200467T TR 200200467 T2 TR200200467 T2 TR 200200467T2
Authority
TR
Turkey
Prior art keywords
delivery system
drug delivery
oral drug
stomach
hydrodynamic balancing
Prior art date
Application number
TR2002/00467T
Other languages
English (en)
Inventor
Talwar Naresh
N. Staniforth John
J. Tobyn Michael
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of TR200200467T2 publication Critical patent/TR200200467T2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Mevcut bulus, en az bir ilaç maddesi, seker(ler), gaz olusturma bilesenleri ve istege bagli olarak farmasötik açidan kabul edilebilir yardimci bilesenlerden olusan oldukça gözenekli bir matris içeren, midede tutulan oral ilaç verme sistemi ile ilgilidir. Topaklar (çok partikülatli veya tek üniteli dozaj formu), taneler, granüller veya kapsüller formundaki farmasötik kompozisyon midede tutulurken ilaç(lar) uzun bir süre zarfinda ince bagirsagin üst kisimlarinda ve mide seviyelerinde seçici olarak birakilir.
TR2002/00467T 1999-08-04 2000-08-01 Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi. TR200200467T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1999/001386 WO2001010405A1 (en) 1999-08-04 1999-08-04 Hydrodynamically balanced oral drug delivery system

Publications (1)

Publication Number Publication Date
TR200200467T2 true TR200200467T2 (tr) 2002-08-21

Family

ID=11004886

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00467T TR200200467T2 (tr) 1999-08-04 2000-08-01 Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.

Country Status (21)

Country Link
EP (1) EP1206249A4 (tr)
JP (1) JP2003506400A (tr)
CN (1) CN1376059A (tr)
AP (1) AP2002002410A0 (tr)
AU (2) AU5060499A (tr)
BR (1) BR0012981A (tr)
CA (1) CA2378468A1 (tr)
CZ (1) CZ2002415A3 (tr)
EA (1) EA200200126A1 (tr)
HK (1) HK1047226A1 (tr)
HR (1) HRP20020108A2 (tr)
HU (1) HUP0202497A3 (tr)
IL (1) IL147966A0 (tr)
MX (1) MXPA02001272A (tr)
NZ (1) NZ516959A (tr)
OA (1) OA12003A (tr)
PL (1) PL353321A1 (tr)
SK (1) SK1832002A3 (tr)
TR (1) TR200200467T2 (tr)
WO (2) WO2001010405A1 (tr)
ZA (1) ZA200200926B (tr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100457458B1 (ko) * 2001-04-02 2004-11-17 삼아약품 주식회사 속용정 및 그의 제조방법
ATE477795T1 (de) 2001-07-04 2010-09-15 Sun Pharma Advanced Res Co Ltd Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
AU2002351798A1 (en) * 2001-10-29 2003-05-12 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
US20050226926A1 (en) 2002-07-25 2005-10-13 Pfizer Inc Sustained-release tablet composition of pramipexole
WO2005020879A2 (en) * 2003-08-27 2005-03-10 Vecta Ltd. Compositions for treating pathologies that necessitate suppression of gastric acid secretion
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
EP2135602A1 (en) 2004-08-13 2009-12-23 Boehringer Ingelheim International GmbH Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
EP1690540A1 (en) * 2005-02-15 2006-08-16 Neuro3D Composition comprising ocaperidone
ES2643140T3 (es) 2005-12-22 2017-11-21 Oakwood Laboratories L.L.C. Sistema de suministro de liberación lenta sublimable y procedimiento de realización del mismo
EP1886665A1 (en) * 2006-08-01 2008-02-13 Boehringer Ingelheim Pharma GmbH & Co. KG Gastro retentive delivery system
ATE476176T1 (de) 2007-03-02 2010-08-15 Farnam Co Inc Wachsähnliches material enthaltende tabletten mit verzögerter freisetzung
WO2010020098A1 (zh) 2008-08-18 2010-02-25 北京天衡药物研究院 胃滞留药物释出系统及其制备方法和用途
JP2012500221A (ja) 2008-08-15 2012-01-05 ディポメド,インコーポレイティド Cns障害の処理及び予防のための胃保持性医薬組成物
BRPI0914080A2 (pt) 2008-10-08 2015-10-27 Bioplus Life Sciences Pvt Ltda "sistema de liberação de dosagem controlada, método de administração e processo de preparação do mesmo"
EP2283824B1 (en) 2009-07-30 2017-04-19 Special Products Line S.p.A. Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
JP2013103879A (ja) * 2011-11-10 2013-05-30 Nakanihon Capsule Co Ltd ハードカプセル
KR102241487B1 (ko) 2013-02-20 2021-04-16 주식회사 종근당 제어방출 펠릿으로 된 약제학적 조성물
EP2968181B1 (en) * 2013-03-15 2019-10-16 Aprecia Pharmaceuticals LLC Rapidly dispersible dosage form of topiramate
CN103462917A (zh) * 2013-09-12 2013-12-25 南京正宽医药科技有限公司 一种用于抗病毒的阿昔洛韦片剂及其制备方法
CN117898368A (zh) * 2016-06-14 2024-04-19 Evah 营养公司 包含饲料添加剂的动物饲料颗粒、其制备和使用方法
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
DK3648747T3 (da) 2017-06-16 2022-11-28 Amneal Complex Products Res Llc Gastroretentive doseringsformer til vedvarende frigivelse af lægemidler
CN107349195A (zh) * 2017-08-22 2017-11-17 安徽省肿瘤医院 一种维拉帕米在制备治疗转移性肝癌药物中的用途
CN107375287B (zh) * 2017-08-22 2019-11-29 安徽省肿瘤医院 一种硫酸阿托品在制备治疗原发性肝癌药物中的用途
CN107441115A (zh) * 2017-08-22 2017-12-08 安徽省肿瘤医院 一种维拉帕米联合碳酸氢钠在制备原发性肝癌治疗药物中的用途
EP4056172A1 (en) 2018-06-18 2022-09-14 Amneal Complex Products Research LLC Extended release compositions comprising pyridostigmine
ES2901522T3 (es) * 2018-06-27 2022-03-22 Amneal Complex Products Res Llc Sistemas de suministro de fármacos gastrorretentivos osmóticos autorregulados
US11389398B2 (en) 2019-05-14 2022-07-19 Clexio Biosciences Ltd. Gastroretentive treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
WO2022195476A1 (en) 2021-03-15 2022-09-22 Clexio Biosciences Ltd. Gastroretentive devices for assessment of intragastric conditions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH675537A5 (tr) * 1988-03-25 1990-10-15 Ciba Geigy Ag
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
ATE119766T1 (de) * 1989-10-26 1995-04-15 Nippon Shinyaku Co Ltd Zubereitung für den magen.
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
GB9322314D0 (en) * 1993-10-29 1993-12-15 Scherer Ltd R P Foam generating capsules
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
GB9418530D0 (en) * 1994-09-14 1994-11-02 Glaxo Group Ltd Medicaments
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
IT1293764B1 (it) * 1997-07-23 1999-03-10 Chiesi Farma Spa Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua

Also Published As

Publication number Publication date
HK1047226A1 (zh) 2003-02-14
AU774957B2 (en) 2004-07-15
IL147966A0 (en) 2002-09-12
JP2003506400A (ja) 2003-02-18
HRP20020108A2 (en) 2003-12-31
PL353321A1 (en) 2003-11-17
WO2001010419A1 (en) 2001-02-15
CN1376059A (zh) 2002-10-23
OA12003A (en) 2006-04-18
BR0012981A (pt) 2002-06-18
ZA200200926B (en) 2002-11-27
EP1206249A1 (en) 2002-05-22
AP2002002410A0 (en) 2002-03-31
EA200200126A1 (ru) 2002-10-31
MXPA02001272A (es) 2002-07-22
AU6309900A (en) 2001-03-05
SK1832002A3 (en) 2002-08-06
HUP0202497A2 (hu) 2002-11-28
NZ516959A (en) 2003-10-31
HUP0202497A3 (en) 2004-05-28
EP1206249A4 (en) 2004-12-22
AU5060499A (en) 2001-03-05
CA2378468A1 (en) 2001-02-15
CZ2002415A3 (cs) 2002-08-14
WO2001010405A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
TR200200467T2 (tr) Hidrodinamik dengelemeli oral yoldan ilaç verme sistemi.
NO923590D0 (no) Doseringsform for avgivelse av medikament til tarmen
HK1050493A1 (en) Shell-and-core dosage form approaching zero-order drug release
ES2313797T3 (es) Composicion de metilfenidato de liberacion modificada multiparticulada.
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
MY102459A (en) Oral sustained release pharmaceutical preparation.
CA2112679A1 (en) Dosage form for delivering drug in short-time period
ES2035821T3 (es) Sistema de administracion enterica dirigida.
HUP0000943A2 (hu) Expandálható gasztro-retentív terápiás rendszer szabályozott hatóanyag felszabadítással a gyomor-béltraktusban
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
DK0932388T3 (da) Doseringsform og fremgangsmåde til indgivelse af lægemidler
KR850700212A (ko) 서방성 약제학적 캼셀제
FR2752732B1 (fr) Forme galenique a liberation prolongee de milnacipran
DE69940674D1 (de) Orale verabreichung von adenosin analogen
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
HUP0100347A2 (hu) Gyomorvédett omeprazol mikrogranulátumok, eljárás előállításukra és ezeket tartalmazó gyógyászati készítmények
TR199902175T2 (tr) Parasetamol içeren yutma tableti.
KR900015724A (ko) 메베버린 용량 형태
BR0212155A (pt) Composição farmacêutica
MXPA03011317A (es) Comprimido masticable que comprende paracetamol.
HUP0104476A2 (hu) Hidroxi-propil-mutil-cellulóz kapszulákban formázott gyógyszerkészítmények
HUP0203148A2 (hu) Mirtazapint tartalmazó orálisan dezintegrálódó készítmény
MY100780A (en) Azumolene dosage form.
MA26788A1 (fr) COMPOSITIONS PHARMACEUTIQUES DESTINÉES à L'ADMINISTRATION PAR VOIE ORALE DE PHLOROGLUCINOL ET LEUR PRÉPARATION